•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.InMode (INMD) Soars 6.8%: Is Further Upside Left in the Stock?
InMode: Strategic Capital Allocation Unlocks Shareholder Value (Rating Upgrade)
3 Undervalued MedTech Stocks to Buy for 2025 Gains Amid S&P 500 Rally
InMode to Present at the 24th Annual Needham Virtual Healthcare Conference
Is InMode (INMD) Stock Undervalued Right Now?
InMode Responds to Doma Perpetual's Letters
InMode to Present at Upcoming Investor Conferences
InMode: Plastic Surgery Boom, Cash Flow, And Cheap
InMode Ltd. (INMD) Q4 2024 Earnings Call Transcript
InMode Reports Fourth Quarter and Full Year 2024 Financial Results; Board of Directors Has Approved a New Share Repurchase Program
InMode to Participate in the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference
InMode: A Clear Bargain With Unique Risks
InMode to Report Fourth Quarter & Full Year 2024 and Hold Conference Call on February 4, 2025, Earlier than Originally Announced
DOMA Perpetual Sends Letter Urging Board of Directors of InMode Ltd. to Immediately Execute Tender Offer followed by Share Buyback
InMode: Clearly, I Was Too Optimistic (Rating Downgrade)
InMode to Report Fourth Quarter & Full Year 2024 Financial Results and Hold Conference Call on February 6, 2025, Expects Q4 Revenue Between $97.0M-$97.5M
InMode: Product Origination And Undervaluation Make The Stock A Buy
InMode to Present at Upcoming Investor Conferences
InMode: $25/Share Is Closer Than You Think
InMode: A Deep Dive After Q3 Earnings
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.